BlogeventsNewsRBQM LiveUncategorized

What’s in Store at the Industry’s Leading, 100% Virtual RBQM Event?

By August 11, 2022 August 24th, 2022 No Comments

Risk-based quality management (RBQM) supports enhanced quality oversight for the entire clinical trial lifecycle, increasing the efficiency and timeliness of clinical trials and driving accelerated compliance and delivery. As market factors drive the rapid growth of decentralized clinical trials, there’s a huge opportunity for organizations to embrace RBQM to ensure effective oversight of disparate data sources.

CluePoints is proud to sponsor RBQM Live 2022, where industry experts and thought leaders will host panels and presentations around maximizing the impact of a patient-centric approach to clinical research while minimizing any threat to data quality.

Join specialists from across the sector to consider the current climate for RBQM adoption by CROs and sponsors, and look ahead to prevent future implications and ensure success. Here’s what you can expect to experience at RBQM Live on September 8th and 9th.

[Secure Your Complimentary Spot]

Day #1: The Maturity of RBQM & Insights for the Short-Term Future Trends

Join Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of Drug Development, on September 8th for a keynote speech on the current RBQM landscape. RBQM’s evolution reinforces how we improve efficiencies and adds value to clinical research. Getz will share relevant research study findings and open the discussion to the audience.

Other topics of the day:

  • Getting in front of new regulations for 100% compliance
  • Interpreting QTLs based on where they are and where they will be
  • Diversifying RBQM for tSDV, tSDR, and site monitoring strategies
  • Understanding the risks of decentralized trials as sources of data increase

Day #2: The Advancement of RBQM & Where We’re Heading in the Long-Term Future

Today’s keynote will feature not one but two thought leaders: Demetris Zambas, Global Clinical Operations Leader at Pfizer and Mayank Anand, VP and Global Head Data Strategy of Management and Centralized Monitoring at GSK. Tune into this fireside chat designed to unravel the role of Artificial Intelligence and Machine Learning in the future of RBQM.

Other topics of the day:

  • RBQM Best Practice Defined by Leading Industry Working Groups
  • Leveraging RBQM in new and exciting ways you never envisioned
  • Discussing the transformative outcomes from COVID that are here to stay

[Secure You Complimentary Spot & Download the Full Agenda] 

Tell everyone you’re attending using #RBQMLive22 on social media and share the link to register with your colleagues.

Get to Know CluePoints Better

Learn how our technology and approach to RBQM can benefit your upcoming clinical trials. Contact us today at [email protected] to learn more, request a demo, and begin our journey together.